Maravai LifeSciences Holdings Inc expected to post breakeven results a share - Earnings Preview

Maravai Lifesciences Holdings

06/08/2024 03:07

* Maravai LifeSciences Holdings Inc  MRVI.OQ   MRVI.O  is
expected
to show a rise in quarterly revenue when it reports  results on
August 7 for the period ending June 30 2024
    * The San Diego California-based  company is expected to
report a
3.9% increase in revenue to $71.634 million from $68.91 million
a year ago, according to the mean estimate from 11 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Maravai LifeSciences
Holdings
Inc is for breakeven results per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Maravai
LifeSciences Holdings Inc is $10.00​, above​ its last closing
price of $9.19. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.03       -0.03      -0.02     Beat    21.4
 Dec. 31 2024  -0.01       -0.01      0.01      Beat    184.6
 Sep. 30 2023  0.00        0.01       -0.01     Missed  -257.2
                                                        ​
 Jun. 30 2023  0.01        0.01       0.00      Missed  -100
 ​​Jan.        0.04        0.04       0.03      Missed  -17.2
 1 0001                                                 
 Jan. 1 0001   0.35        0.34       0.35      Beat    2.4​
 Jan. 1 0001   0.33        0.33       0.37      Beat    12.2
 Jun. 30 2022  0.45        0.45       0.54      Beat    18.8
 This summary was machine generated August 6 at 02:07 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)